tnf-kinoid
Vaccineexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2008 (NCT00808262)
Timeline
Indications
Mechanism of action
- TNF-alphaImmunity, active
TNF immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- tnf kinoid
- tnf-kinoid
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01911234 | Phase 2 | Sep 1, 2013 | Neovacs |
| NCT01291810 | Phase 2 | Feb 1, 2011 | Neovacs |
| NCT01040715 | Phase 2 | Dec 1, 2009 | Neovacs, Université catholique de Louvain |
| NCT00808262 | Phase 1/Phase 2 (Phase 2) | Oct 1, 2008 | Neovacs |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Neovacs | For profit | 4 | 4 | 1 | 2008 |
| Université catholique de Louvain | Academic/Hospital | 1 | 0 | 1 | 2009 |
2 organizations
Page 1 / 1